Santen Pharmaceutical Co (TSE:4536) Cyclically Adjusted Book per Share: 円842.79 (As of Mar. 2026)


TSE:4536 Santen Pharmaceutical Co Ltd TSE:4536
81 GF Score
Price 円2,174.00
GF Value 円1,682.91
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Santen Pharmaceutical Co Cyclically Adjusted Book per Share?

Santen Pharmaceutical Co TSE:4536 -2.01% 81 Cyclically Adjusted Book per Share is 円842.79 as of Mar. 2026. GuruFocus rates TSE:4536 with a GF Score™ of 81/100 and a GF Value™ of 円1,682.91 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Santen Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was 円923.246. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円842.79 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Santen Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 3.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Santen Pharmaceutical Co was 8.50% per year. The lowest was 6.50% per year. And the median was 8.10% per year.

As of today (2026-07-09), Santen Pharmaceutical Co's current stock price is 円2174.00. Santen Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was 円842.79. Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 2.58.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Santen Pharmaceutical Co was 4.36. The lowest was 1.43. And the median was 2.38.


Santen Pharmaceutical Co  (TSE:4536) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2174.00/842.79
=2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Santen Pharmaceutical Co was 4.36. The lowest was 1.43. And the median was 2.38.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Santen Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Santen Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Santen Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Santen Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 637.95 698.55 752.78 812.03 842.79

Santen Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 812.03 822.46 828.58 840.00 842.79

TSE:4536 vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


TSE:4536
81GF Score
Santen Pharmaceutical Co Ltd TSE:4536
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Santen Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Santen Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=923.246/112.7000*112.7000
=923.246

Current CPI (Mar. 2026) = 112.7000.

Santen Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 618.666 98.100 710.741
201609 615.758 98.000 708.122
201612 623.452 98.400 714.055
201703 628.093 98.100 721.571
201706 639.625 98.500 731.835
201709 664.681 98.800 758.194
201712 687.468 99.400 779.453
201803 702.544 99.200 798.152
201806 706.743 99.200 802.923
201809 744.087 99.900 839.425
201812 729.859 99.700 825.026
201903 728.855 99.700 823.891
201906 722.156 99.800 815.501
201909 735.648 100.100 828.247
201912 757.132 100.500 849.043
202003 758.262 100.300 852.005
202006 766.356 99.900 864.548
202009 791.054 99.900 892.410
202012 788.861 99.300 895.314
202103 775.804 99.900 875.206
202106 779.358 99.500 882.750
202109 799.378 100.100 899.999
202112 803.798 100.100 904.975
202203 843.149 101.100 939.890
202206 873.755 101.800 967.310
202209 799.350 103.100 873.780
202212 784.708 104.100 849.535
202303 782.815 104.400 845.050
202306 813.491 105.200 871.487
202309 837.046 106.200 888.278
202312 822.494 106.800 867.931
202403 842.642 107.200 885.875
202406 862.320 108.200 898.184
202409 827.654 108.900 856.534
202412 832.068 110.700 847.101
202503 838.524 111.100 850.600
202506 835.964 111.700 843.448
202509 845.869 112.000 851.156
202512 880.966 113.000 878.627
202603 923.246 112.700 923.246

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円842.79 mean?
Santen Pharmaceutical Co (TSE:4536) has a Cyclically Adjusted Book per Share of 円842.79 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Santen Pharmaceutical Co and its competitors.
Is Santen Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Santen Pharmaceutical Co's current Cyclically Adjusted Book per Share is 円842.79. Overall, Santen Pharmaceutical Co has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Santen Pharmaceutical Co's Cyclically Adjusted Book per Share compare to LLY and JNJ?
Santen Pharmaceutical Co's Cyclically Adjusted Book per Share of 円842.79 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Santen Pharmaceutical Co and its competitors. Santen Pharmaceutical Co's current Cyclically Adjusted Book per Share is 円842.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Santen Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Santen Pharmaceutical Co (TSE:4536) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,682.91, compared to a current price of 円2,174.00 — trading 29.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is 円842.79. Santen Pharmaceutical Co's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Santen Pharmaceutical Co (TSE:4536), the current Cyclically Adjusted Book per Share is 円842.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Santen Pharmaceutical Co (TSE:4536) Overvalued in 2026?

Based on GuruFocus' analysis, Santen Pharmaceutical Co stock appears to be overvalued. The current stock price of 円2,174.00 is trading 29.2% above its estimated GF Value™ of 円1,682.91. GuruFocus considers Santen Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4536:

  • Cyclically Adjusted Book per Share: 円842.79
  • GF Value™: 円1,682.91 vs. price of 円2,174.00 (29.2% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the TSE:4536 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Santen Pharmaceutical Co Business Description

Other Exchanges SNPHY:USA
Address 4-20 Ofukacho, Grand Front Osaka Tower A, Kita-ku, Osaka Prefecture, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
81GF Score

Get the complete analysis for TSE:4536

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,174.00
Price
円1,682.91
GF Value